<div>Fun<wbr />ctional High-Risk</div>

A detailed infographic representing the fun<wbr>ctional high-risk patient group in oncology, showcasing key statistics and treatment response graphs, in a professional and educational style.

Functional High-Risk Quiz

Test your knowledge on the functional high-risk group in therapy! This quiz will assess your understanding of early relapse subgroups, treatment efficacy, and patient outcomes based on recent research.

Key Topics Covered:

Progression timelines
Response rates in therapy
Patient demographics and cytogenetics

9 Questions2 MinutesCreated by AnalyzingData342

Patients who progress within ______________ after initial therapy are considered a functional high-risk group.

60-90 days

6-12 months

12-18 months

1-2 years

The early relapse subgroup defined within the Poster analysis were patients with 1 prior line of therapy who relapsed....

<12 months after initiating 1L therapy

>18 months after initiating 1L therapy

<18 months after initiating 1L therapy

After receiving lenalidomide-based 1L therapy

MPFS for DVd vs Vd in the early relapse sub-group was...?

12.6 vs 6.2

15.4 vs 9.0

27.7 vs 7.9

36.9 vs 11.7

The mPFS for DVd vs Vd was 15.4 vs 9.0 in the early relapse sub-group with a HR of 0.51. What is the RRR?

49%

51%

15.4%

9.0%

What percentage of patients in the Vd arm of the early relapse sub-group achieved MRD-negativity?

13.3%

3.2%

Not reported

What percentage of patients in the DVd arm of the early relapse sub-group also had high-risk cytogenetics?

Not reported

14.5%

17.6%

26.3%

Comparing the response of early relapse patients that received DVd vs Vd, what level of response was considered statistically significant?

VGPR

None were statistically significant

Unlock and Upgrade

Remove all limits from your Quizzes

Functional High-Risk

Functional High-Risk Quiz

More Quizzes